Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 10, 2013, Pages 750-755

  Kaur, Ramandeep ^a   Matharoo, Kawaljit ^a   Arora, Punit ^b   Bhanwer, A J S ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

^b Diabetic Clinic and Research Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; PROTECTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGED; ALLELES; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84884536708     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0227     Document Type: Article

References (39)

1. American Diabetes Association (2011) Diagnosis and classification of Diabetes mellitus. Diabetes Care 34:1
2. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis epidemiology, pathophysiology, and management. JAMA 287:2570-2581
3. Bucova M, Lietava J, Mrazek F, et al. (2009) The MCP-1-2518(A/ G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the slovak population. Bratisl Lek Listy 110:385-389
4. Cermakova Z, Petrkova J, Arakelyan A, et al. (2005) The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet 32:315-318
5. Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. J Circ Res 95:858-866
6. Deshmane SL, Kremlev S, Amini S, et al. (2009) Monocyte chemoattractant protein (MCP-1): An overview. J Interferon Cytokine Res 29:313-326
7. Eriksson EE (2004) Mechanisms of leukocyte recruitment to atherosclerotic lesions: Future prospects. Curr Opin Lipidol 15:553-558
8. Feskens EJ, Kromhout D (1992) Glucose tolerance and the risk of cardiovascular disease: The Zutphen study. J Clin Epidemiol 45:1327-1334.
9. Freeman DJ, Norrie J, Caslake MJ, et al. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600
10. Gautier A, Roussel R, Ducluzeau PH, et al. (2010) Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: Influence of baseline BMI. Diabetes Care 33:1850-1852
11. Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 453-458
12. Hubert HB, Feinleib M, McNamara PM, et al. (1983) Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977
13. Jemaa R, Rojbani H, Kallel A, et al. (2008) Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta 390:122-125
14. Jialal I, Devaraj S, Venugopal SK (2004) C-reactive protein: Risk marker or mediator in atherothrombosis? J Hypertens 44:6-11
15. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473-481
16. Kamath A, Shivaprakash G, Adhikari P (2011) Body mass index and Waist circumference in Type 2 Diabetes mellitus patients attending a diabetes clinic. Int J Biol Med Res 2:636-638
17. Kouyama K, Miyake K, Zenibayashi M, et al. (2007) Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes. Kobe J Med Sci 53:345-354
18. Liao Y, Lin S, Hsu C (2011) Waist circumference is a better predictor than body mass index of insulin resistance in type 2 diabetes. Int J Diabetes Metab 19:35-40
19. Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83:456S-460S.
20. Mahgoub E, Afify IR, Aal RA, et al. (2011) Association between the monocyte chemoattractant protein-1 -2518G/A gene polymorphism and acute myocardial infarction patients among Egyptian population. Blood Coagul Fibrinolysis 22:7-13
21. Manson JE, Colditz GA, Stampfer MJ, et al. (1990) A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322:882-889
22. Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
23. Misra A, Chowbey P, Makkar BM, et al. (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 57:163-170
24. Mohan V, Shanthirani CS, Deepa R (2003) Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors -The Chennai Urban Population Study (CUPS 14). J Assoc Physicians India 51:771-777
25. Mohan V, Shanthirani S, Deepa R, et al. (2001) Intra-urban differences in the prevalence of the metabolic syndrome in southern India-The Chennai Urban Population Study (CUPS No. 4). J Diabet Med 18:280-287
26. Moon JY, Jeong L, Lee S, et al. (2007) Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 22:810-814
27. Rosengren A, Wedel H, Wilhelmsen L (1999) Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 20:269-277
28. Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: Basic chemokines grammar for immune cells. Annu Rev Immunol 22:891-928
29. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344-348
30. Simeoni E, Hoffmann MM, Winkelmann BR, et al. (2004) Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47:1574-1580
31. Snehalatha C, Viswanathan V, Ramachandran A (2003) Cut off values for normal anthropometric variables in Asian Indian adults. Diabetes Care 26:1380-1384
32. Sonmez K, Akçakoyun M, et al. (2003) Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio). Int J Obes Relat Metab Disord 27:341-346
33. Szalai C, Duba J, Prohaszka Z, et al. (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 158:233-239
34. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr Rev 21:697-738
35. Williams CM (2004) Lipid metabolism in women. Proc Nutr Soc 63:153-160
36. Yang B, Houlberg K, Millward A, et al. (2004) Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications. Cytokine 26:114-1121
37. Yoshimura T, Robinson EA, Tanaka S, et al. (1989) Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol 142:1956-1962
38. Zhang X, Han Y, Kang J, et al. (2009) A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin Chim Acta 403:241-243
39. Zietz B, Buchler C, Herfarth H, et al. (2005) Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518A/ G promoter polymorphism. Diabetes Obes Metab 7:570-578 Science and Technology